Latin American, Caribbean national rotavirus immunization campaigns show success, CDC report says

NewsGuard 100/100 Score

"Fourteen of the 32 countries in Latin America and the Caribbean make the rotavirus vaccine available for all infants via national programs," according to a report published Friday in the CDC's "Morbidity and Mortality Weekly Report," United Press International reports. Approximately "seven million infants, 66 percent of the infants born in Latin America and the Caribbean, were immunized in 2010 against rotavirus infection -- the most common cause of severe diarrhea among infants and young children, and one of several viruses that cause infections often called stomach flu," the news agency writes. The WHO recommends rotavirus vaccination for children worldwide, the report noted, stating, "Studies from countries in this region have shown declines in the burden of hospitalizations and deaths related to severe diarrhea after rotavirus vaccine introduction," according to UPI (12/2).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses